26X-14817-13922
2 vaccinations
12 coded responses
21 check-ins
12 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 129 / NY
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Moderna
-
2021-01-04
Registered in v-safe
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: Short of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Survey response — days 1–6 daily, dose 1MedDRA: Hot flush, Hyperhidrosis, Pyrexia — Feeling: Fair · Fever · HeadacheFree text: “Hot flash†type episode fever and diaphoretic. Lasts a few minutes, fever then gone.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Survey response — day 7, dose 1MedDRA: Middle ear effusion, SARS-CoV-2 test — Feeling: Poor · Fever · Fatigue or tiredness · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Feels like fluid in ear canals occasionally · Healthcare visit (other): Covid test ordered due to vaccine received 7 days ago, didn't think symptoms any longer vaccine relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 7, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-14
Survey response — day 14, dose 1MedDRA: Fatigue, Hypersomnia, SARS-CoV-2 test — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Temp continues daily to 99.4-99.9. Fatigue and sleeping a lot past week · Healthcare visit (other): CXR, labs and another covid testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-23
Survey response — day 21, dose 1MedDRA: Dyspnoea, Oxygen saturation decreased, Pyrexia, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Fevers continue to 99.8 daily. Increased shortness of breath, O2 sats dropping with activity accompanied by tachycardia to 130s with activityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-28
Survey response — day 28, dose 1MedDRA: Dyspnoea, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Continued temps, shortness of breath and ta by arsia with activity · Healthcare visit (other): CT scans, more lab work, stress test tomorrowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-11
Dose 2 — Moderna
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Night sweats, Tachycardia — Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Night sweats, short of breath and tachycardia with minimal activityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-02-18
Survey response — day 7, dose 2MedDRA: Dyspnoea, Tachycardia — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Short of breath & tachycardia with minimal activityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
-
2021-03-04
Survey response — day 21, dose 2MedDRA: Body temperature, Dyspnoea, Headache, Tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Splitting headache. Sob and tachycardia with activity continues. Low grade temperatures continueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
-
2021-03-18
Survey response — day 35, dose 2MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased Dyspnea with exertion and talking on phone.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
-
2021-05-13
Survey response — 3 months, dose 2MedDRA: Office visit, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Continued tachycardia with activity · Healthcare visit (other): Office visitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
- 2021-08-12
- 2022-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-02-11 | Moderna |
Call center
5 call center cases
5 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Short of breath
Systemic reaction (other): “Hot flash†type episode fever and diaphoretic. Lasts a few minutes, fever then gone.
Release 1 — day 7, dose 1
Systemic reaction (other): Feels like fluid in ear canals occasionally
Healthcare visit (other): Covid test ordered due to vaccine received 7 days ago, didn't think symptoms any longer vaccine related
Release 2 — day 14, dose 1
Symptoms: Temp continues daily to 99.4-99.9. Fatigue and sleeping a lot past week
Healthcare visit (other): CXR, labs and another covid test
Release 2 — day 21, dose 1
Symptoms: Fevers continue to 99.8 daily. Increased shortness of breath, O2 sats dropping with activity accompanied by tachycardia to 130s with activity
Release 2 — day 28, dose 1
Symptoms: Continued temps, shortness of breath and ta by arsia with activity
Healthcare visit (other): CT scans, more lab work, stress test tomorrow
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Night sweats
Systemic reaction (other): Night sweats, short of breath and tachycardia with minimal activity
Release 4 — day 7, dose 2
Systemic reaction (other): Short of breath & tachycardia with minimal activity
Release 5 — day 21, dose 2
Symptoms: Splitting headache. Sob and tachycardia with activity continues. Low grade temperatures continue
Release 5 — day 35, dose 2
Symptoms: Increased Dyspnea with exertion and talking on phone.
Release 8 — 3 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Body temperature | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersomnia | ✓ | ✓ | ✓ |
| SD | Oxygen saturation decreased | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Middle ear effusion | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release